Peyer James (CIK 1843594) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-01). Recent activity: Sell SNSE (24,524 shares), Sell SNSE (476 shares), Sell SNSE (3,105 shares), Sell SNSE (2,666 shares), Buy SNSE (395 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-01 | Sensei Biotherapeutics, Inc. (SNSE) | 10% Owner | Sell | 24,524 | $490,480 |
| 2026-06-01 | Sensei Biotherapeutics, Inc. (SNSE) | 10% Owner | Sell | 476 | $10,063 |
| 2025-12-10 | Sensei Biotherapeutics, Inc. (SNSE) | 10% Owner | Sell | 3,105 | $26,672 |
| 2025-12-10 | Sensei Biotherapeutics, Inc. (SNSE) | 10% Owner | Sell | 2,666 | $21,195 |
| 2025-12-10 | Sensei Biotherapeutics, Inc. (SNSE) | 10% Owner | Buy | 395 | $2,528 |
| 2025-12-10 | Sensei Biotherapeutics, Inc. (SNSE) | 10% Owner | Sell | 395 | $3,176 |
| 2025-12-10 | Sensei Biotherapeutics, Inc. (SNSE) | 10% Owner | Sell | 446 | $3,532 |
| 2025-12-08 | Sensei Biotherapeutics, Inc. (SNSE) | 10% Owner | Sell | 5,000 | $45,300 |
| 2025-12-08 | Sensei Biotherapeutics, Inc. (SNSE) | 10% Owner | Sell | 14,508 | $165,391 |
| 2025-12-08 | Sensei Biotherapeutics, Inc. (SNSE) | 10% Owner | Sell | 1,745 | $21,446 |
| 2025-12-08 | Sensei Biotherapeutics, Inc. (SNSE) | 10% Owner | Sell | 42 | $553 |
来源：SEC Form 4 申报文件 · 截至 2026-06-01